Articles related to CLINICAL STUDY

The study underscores the potential influence of pharmaceutical industry payments on the delivery of non-recommended or low value interventions in cancer treatment. It highlights the need for increased transparency and scrutiny in the financial relationships between physicians and the industry.

The study’s findings suggest a potential paradigm shift in the management of cancer patients with isolated distal DVT. With the 12-month edoxaban regimen reducing the occurrence of the primary composite endpoint to just 1.0% compared to 7.2% in the three-month group, this could represent a significant advancement in patient care.

A recent study from Fox Chase Cancer Center has revealed that as many as 23% of cystic renal masses may carry high-grade, or aggressive, disease. This finding challenges the prevailing assumption of their low-risk nature and underscores the need for more discerning diagnostic and treatment strategies.

The study found that both primary care physicians and nurse practitioners averaged approximately 1.7 inappropriate prescriptions for every 100 prescriptions written. This finding underscores the shared challenge of inappropriate prescribing across healthcare professions.

A recent study involving 4,400 participants revealed that two major statins—rosuvastatin and atorvastatin—are equally effective at reducing heart attacks, strokes, and all-cause deaths. However, it was found that the rosuvastatin group was more likely (7.2%) to develop type 2 diabetes than the atorvastatin group (5.3%).

This double-blind, placebo-controlled trial suggests that topiramate monotherapy may be an effective treatment for civilian PTSD. Despite the decrease in total CAPS score not being statistically significant, topiramate-treated patients exhibited significant reductions in reexperiencing symptoms.